Annual SGA
$5.99 M
+$245.00 K+4.26%
December 31, 2023
Summary
- As of February 8, 2025, COCP annual SGA is $5.99 million, with the most recent change of +$245.00 thousand (+4.26%) on December 31, 2023.
- During the last 3 years, COCP annual SGA has risen by +$424.00 thousand (+7.62%).
- COCP annual SGA is now -11.46% below its all-time high of $6.76 million, reached on December 31, 2015.
Performance
COCP SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$1.80 M
+$660.00 K+57.89%
September 30, 2024
Summary
- As of February 8, 2025, COCP quarterly SGA is $1.80 million, with the most recent change of +$660.00 thousand (+57.89%) on September 30, 2024.
- Over the past year, COCP quarterly SGA has dropped by -$49.00 thousand (-2.65%).
- COCP quarterly SGA is now -58.12% below its all-time high of $4.30 million, reached on September 30, 2011.
Performance
COCP Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.29 B
-$18.70 M-1.47%
September 30, 2024
Summary
- As of February 8, 2025, COCP TTM SGA is -$1.29 billion, with the most recent change of -$18.70 million (-1.47%) on September 30, 2024.
- Over the past year, COCP TTM SGA has dropped by -$1.30 billion (-22338.18%).
- COCP TTM SGA is now -2095921.10% below its all-time high of -$61.60 thousand.
Performance
COCP TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
COCP Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.3% | -2.6% | -10000.0% |
| 3 y3 years | +7.6% | +48.1% | -10000.0% |
| 5 y5 years | +37.6% | +48.1% | -10000.0% |
COCP Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +10.4% | -2.6% | +85.8% | -27.4% | at low |
| 5 y | 5-year | at high | +23.2% | -11.2% | +85.8% | -62.9% | at low |
| alltime | all time | -11.5% | >+9999.0% | -58.1% | +169.8% | <-9999.0% | at low |
Cocrystal Pharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.80 M(+57.9%) | $5.55 M(-0.9%) |
| Jun 2024 | - | $1.14 M(-5.6%) | $5.60 M(-6.6%) |
| Mar 2024 | - | $1.21 M(-13.7%) | $5.99 M(+0.1%) |
| Dec 2023 | $5.99 M(+4.3%) | $1.40 M(-24.3%) | $5.99 M(+3.2%) |
| Sep 2023 | - | $1.85 M(+20.2%) | $5.81 M(+0.5%) |
| Jun 2023 | - | $1.54 M(+27.7%) | $5.78 M(+2.9%) |
| Mar 2023 | - | $1.20 M(-0.9%) | $5.62 M(-2.2%) |
| Dec 2022 | $5.75 M(+5.9%) | $1.22 M(-33.3%) | $5.75 M(+4.5%) |
| Sep 2022 | - | $1.82 M(+32.5%) | $5.50 M(-0.5%) |
| Jun 2022 | - | $1.38 M(+3.2%) | $5.53 M(+1.9%) |
| Mar 2022 | - | $1.33 M(+37.6%) | $5.42 M(+3.3%) |
| Dec 2021 | $5.43 M(-2.5%) | $969.00 K(-47.6%) | $5.25 M(-5.6%) |
| Sep 2021 | - | $1.85 M(+45.4%) | $5.56 M(+15.0%) |
| Jun 2021 | - | $1.27 M(+9.5%) | $4.83 M(-13.5%) |
| Mar 2021 | - | $1.16 M(-9.2%) | $5.59 M(+0.4%) |
| Dec 2020 | $5.57 M(+14.5%) | $1.28 M(+14.0%) | $5.57 M(+0.2%) |
| Sep 2020 | - | $1.12 M(-44.7%) | $5.55 M(-1.8%) |
| Jun 2020 | - | $2.03 M(+78.1%) | $5.66 M(+20.9%) |
| Mar 2020 | - | $1.14 M(-10.0%) | $4.68 M(-3.8%) |
| Dec 2019 | $4.86 M(+11.7%) | $1.27 M(+3.5%) | $4.86 M(+1.5%) |
| Sep 2019 | - | $1.22 M(+16.4%) | $4.79 M(+6.0%) |
| Jun 2019 | - | $1.05 M(-20.6%) | $4.52 M(+0.8%) |
| Mar 2019 | - | $1.32 M(+10.7%) | $4.48 M(+3.1%) |
| Dec 2018 | $4.35 M(+78.4%) | $1.20 M(+25.5%) | $4.35 M(+12.0%) |
| Sep 2018 | - | $952.00 K(-6.0%) | $3.88 M(+6.4%) |
| Jun 2018 | - | $1.01 M(-14.9%) | $3.65 M(+41.4%) |
| Mar 2018 | - | $1.19 M(+63.5%) | $2.58 M(+5.7%) |
| Dec 2017 | $2.44 M(-41.1%) | $728.00 K(+1.5%) | $2.44 M(+9.8%) |
| Sep 2017 | - | $717.00 K(-1403.6%) | $2.22 M(+70.1%) |
| Jun 2017 | - | -$55.00 K(-105.2%) | $1.31 M(-59.1%) |
| Mar 2017 | - | $1.05 M(+105.9%) | $3.20 M(-22.8%) |
| Dec 2016 | $4.14 M | $510.00 K(-356.3%) | $4.14 M(-36.2%) |
| Sep 2016 | - | -$199.00 K(-110.8%) | $6.49 M(-20.1%) |
| Jun 2016 | - | $1.84 M(-7.8%) | $8.13 M(-0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | $1.99 M(-30.4%) | $8.19 M(+19.9%) |
| Dec 2015 | $6.76 M(+289.5%) | $2.86 M(+99.2%) | $6.83 M(+59.3%) |
| Sep 2015 | - | $1.44 M(-24.3%) | $4.29 M(+33.8%) |
| Jun 2015 | - | $1.90 M(+198.9%) | $3.21 M(+77.4%) |
| Mar 2015 | - | $635.00 K(+98.4%) | $1.81 M(+4.0%) |
| Dec 2014 | $1.74 M(+693.2%) | $320.00 K(-9.3%) | $1.74 M(+17.6%) |
| Sep 2014 | - | $353.00 K(-29.3%) | $1.48 M(+25.3%) |
| Jun 2014 | - | $499.00 K(-11.7%) | $1.18 M(+61.3%) |
| Mar 2014 | - | $565.00 K(+841.7%) | $731.00 K(+233.8%) |
| Dec 2013 | $219.00 K(-89.4%) | $60.00 K(+9.1%) | $219.00 K(-109.0%) |
| Sep 2013 | - | $55.00 K(+7.8%) | -$2.42 M(+127.5%) |
| Jun 2013 | - | $51.00 K(-3.8%) | -$1.06 M(-338.4%) |
| Mar 2013 | - | $53.00 K(-102.1%) | $446.40 K(-79.8%) |
| Dec 2012 | $2.06 M(-66.4%) | -$2.58 M(-282.7%) | $2.21 M(-47.7%) |
| Sep 2012 | - | $1.41 M(-9.6%) | $4.22 M(-40.6%) |
| Jun 2012 | - | $1.56 M(-14.0%) | $7.11 M(+4.0%) |
| Mar 2012 | - | $1.81 M(-421.2%) | $6.84 M(+11.1%) |
| Dec 2011 | $6.15 M(-7.1%) | -$565.10 K(-113.1%) | $6.15 M(-30.7%) |
| Sep 2011 | - | $4.30 M(+233.3%) | $8.87 M(+41.7%) |
| Jun 2011 | - | $1.29 M(+14.1%) | $6.26 M(-0.6%) |
| Mar 2011 | - | $1.13 M(-47.6%) | $6.30 M(+21.8%) |
| Dec 2010 | $6.62 M(>+9900.0%) | $2.16 M(+28.0%) | $5.17 M(+70.9%) |
| Sep 2010 | - | $1.68 M(+26.8%) | $3.03 M(+124.3%) |
| Jun 2010 | - | $1.33 M(>+9900.0%) | $1.35 M(+4569.9%) |
| Mar 2010 | - | $3600.00(-67.0%) | $28.90 K(-32.5%) |
| Dec 2009 | $42.80 K(-23.4%) | $10.90 K(+58.0%) | $42.80 K(+4.6%) |
| Sep 2009 | - | $6900.00(-8.0%) | $40.90 K(-5.5%) |
| Jun 2009 | - | $7500.00(-57.1%) | $43.30 K(-15.4%) |
| Mar 2009 | - | $17.50 K(+94.4%) | $51.20 K(-8.4%) |
| Dec 2008 | $55.90 K(-9.1%) | $9000.00(-3.2%) | $55.90 K(-46.9%) |
| Sep 2008 | - | $9300.00(-39.6%) | $105.30 K(+8.9%) |
| Jun 2008 | - | $15.40 K(-30.6%) | $96.70 K(+18.9%) |
| Mar 2008 | - | $22.20 K(-62.0%) | $81.30 K(+37.6%) |
| Dec 2007 | $61.50 K | $58.40 K(+8242.9%) | $59.10 K(+8342.9%) |
| Sep 2007 | - | $700.00 | $700.00 |
FAQ
- What is Cocrystal Pharma annual SGA?
- What is the all time high annual SGA for Cocrystal Pharma?
- What is Cocrystal Pharma annual SGA year-on-year change?
- What is Cocrystal Pharma quarterly SGA?
- What is the all time high quarterly SGA for Cocrystal Pharma?
- What is Cocrystal Pharma quarterly SGA year-on-year change?
- What is Cocrystal Pharma TTM SGA?
- What is the all time high TTM SGA for Cocrystal Pharma?
- What is Cocrystal Pharma TTM SGA year-on-year change?
What is Cocrystal Pharma annual SGA?
The current annual SGA of COCP is $5.99 M
What is the all time high annual SGA for Cocrystal Pharma?
Cocrystal Pharma all-time high annual SGA is $6.76 M
What is Cocrystal Pharma annual SGA year-on-year change?
Over the past year, COCP annual SGA has changed by +$245.00 K (+4.26%)
What is Cocrystal Pharma quarterly SGA?
The current quarterly SGA of COCP is $1.80 M
What is the all time high quarterly SGA for Cocrystal Pharma?
Cocrystal Pharma all-time high quarterly SGA is $4.30 M
What is Cocrystal Pharma quarterly SGA year-on-year change?
Over the past year, COCP quarterly SGA has changed by -$49.00 K (-2.65%)
What is Cocrystal Pharma TTM SGA?
The current TTM SGA of COCP is -$1.29 B
What is the all time high TTM SGA for Cocrystal Pharma?
Cocrystal Pharma all-time high TTM SGA is -$61.60 K
What is Cocrystal Pharma TTM SGA year-on-year change?
Over the past year, COCP TTM SGA has changed by -$1.30 B (-22338.18%)